AI brief of an SEC Form 8-K · Neogen (NEOG)

Neogen posts $612.2 million Q4 net loss on goodwill impairment; revenue falls 4.8%

Negative Impact 4 of 5 earnings Written later

Neogen reported fiscal 2025 fourth-quarter revenue of $225.5 million, down 4.8% from a year earlier, and a net loss of $612.2 million, or $(2.82) per diluted share, driven mainly by a non-cash goodwill impairment tied to the former 3M Food Safety Division. Adjusted Net Income fell to $11.3 million, or $0.05 per diluted share, from $22.4 million, and the company initiated fiscal 2026 revenue guidance of $820 million to $840 million, which shareholders will weigh against the weaker current results.

Key points

  • Q4 revenue was $225.5 million, down 4.8% from $236.8 million; core revenue declined 2.9%.
  • Q4 net loss was $612.2 million, or $(2.82) per diluted share, versus a $5.4 million loss a year earlier.
  • Q4 Adjusted EBITDA was $40.6 million, an 18.0% margin, versus $53.0 million and 22.4% a year earlier.
  • Fiscal 2026 outlook: revenue of $820 million to $840 million and Adjusted EBITDA of $165 million to $175 million.

The filing

CompanyNeogen (NEOG)
Form8-K, current report
Filed with the SECJul 29, 2025, 7:01 AM ET
Accession number0000950170-25-099379

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.